SALMETEROL XINAFOATE and COUGH

Overview

COUGH is the #4 most commonly reported adverse reaction for SALMETEROL XINAFOATE, manufactured by GlaxoSmithKline LLC. There are 585 FDA adverse event reports linking SALMETEROL XINAFOATE to COUGH. This represents approximately 3.0% of all 19,705 adverse event reports for this drug.

Patients taking SALMETEROL XINAFOATE who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH is a less commonly reported adverse event for SALMETEROL XINAFOATE, but still significant enough to appear in the safety profile.

Other Side Effects of SALMETEROL XINAFOATE

In addition to cough, the following adverse reactions have been reported for SALMETEROL XINAFOATE:

• DYSPNOEA — 1,247 reports
• DRUG INEFFECTIVE — 1,220 reports
• ASTHMA — 901 reports
• HEADACHE — 452 reports
• PNEUMONIA — 402 reports
• NAUSEA — 392 reports
• WHEEZING — 368 reports
• DIZZINESS — 365 reports
• CHEST DISCOMFORT — 355 reports
• FATIGUE — 347 reports

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

Does SALMETEROL XINAFOATE cause COUGH?

COUGH has been reported as an adverse event in 585 FDA reports for SALMETEROL XINAFOATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with SALMETEROL XINAFOATE?

COUGH accounts for approximately 3.0% of all adverse event reports for SALMETEROL XINAFOATE, making it a notable side effect.

What should I do if I experience COUGH while taking SALMETEROL XINAFOATE?

If you experience cough while taking SALMETEROL XINAFOATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages